BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2015
View Archived Issues
Tunable BTK inhibitors from Principia Biopharma show promise for autoimmune diseases
Read More
Fate Therapeutics establishes collaboration on NK cell-based cancer immunotherapeutics
Read More
Enumeral Biomedical updates pipeline progress
Read More
Five Prime and Inhibrx sign GITR antibody research collaboration and license agreement
Read More
Novogen's Anisina receives FDA orphan drug designation for neuroblastoma
Read More
Radius Health's RAD-1901 synergizes with other anticancer agents in breast cancer models
Read More
European Commission approves Evotaz for HIV-1 infection in adults
Read More
Johnson & Johnson highlights progress of second quarter 2015
Read More
Retinal degeneration model devised to test retinal sheet transplants
Read More
Protagonist Therapeutics raises funds to advance pipeline of oral peptide drugs
Read More
Kallikrein-11 shows potential as a brain tumor biomarker
Read More
Immunocore conducts European life sciences' largest private financing
Read More
Achaogen receives NIAID contract to develop novel antibacterials
Read More
Avineuro reports results from phase II trial of AVN-211 as schizophrenia adjuvant therapy
Read More
Bayer presents GnRH receptor antagonists
Read More
FDA grants QIDP designation to iclaprim for hospital-acquired pneumonia
Read More
Gilead discloses Na+ channel modulators
Read More
Merck & Co patents CETP inhibitors
Read More
Esteve divulges multimodal sigma1/mu-opioid receptor ligands
Read More
Amgen reports phase II trial results for blinatumomab in Ph+ ALL
Read More
Respivert and Topivert disclose protein kinase inhibitors
Read More
Yungjin Pharmaceutical starts phase IIa trial of YPL-001 for COPD
Read More
Mesenchymal stem cell-derived exosomes can enhance wound healing
Read More
New Approaches to Neuroblastoma Therapy consortium starts phase I trial of SF-1126
Read More
FDA approves Dysport for upper limb spasticity
Read More